跳至主要内容
临床试验/ChiCTR1900021581
ChiCTR1900021581尚未招募1 期

癌症治療後口腔和腸道微生物群變化的觀察性研究

香港中文大學1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2019年3月5日最近更新:

试验速览

阶段
1 期
状态
尚未招募
发起方
入组人数
300
试验地点
1
主要终点
Changes in gut and oral microbial community profiles measured by 16s and metagenomics sequencing before and after cancer therapy.

研究概览

简要总结

Primary objective:

  1. Delineate changes in gut and oral microbial community profiles of cancer therapy patients before and after therapy. Secondary objectives:
  2. Correlate baseline gut and oral microbial community profiles with the origin of primary tumours;
  3. Correlate changes in gut and oral microbial community profiles with the development of toxicity;
  4. Compare gut and oral microbial community profiles between cancer patients and age-/sex-matched healthy controls (to be recruited under another study with ethics approval obtained).

研究设计

研究类型
观察性研究
主要目的
析因分组(即根据危险因素或暴露因素分组)
盲法
None

入排标准

年龄范围
18 至 100(—)
性别
All

入选标准

  • Chinese people aged 18 or above, no upper age limit;
  • Having newly diagnosed malignant tumour;
  • A new case referred to the Oncology Centre for management.

排除标准

  • Patients who have previously received cancer therapy;
  • Patients who will receive concurrent radiotherapy;
  • Patients with conditions rendering them incapable to answer questionnaires or provide oral and stool samples;
  • Subjects who are unable to give consent.

研究组 & 干预措施

Group A

Chemotherapy

Group B

Immunotherapy

Group C

No anti-cancer therapy

结局指标

主要结局

Changes in gut and oral microbial community profiles measured by 16s and metagenomics sequencing before and after cancer therapy.

次要结局

  • Correlation of gut and oral microbial community profiles measured by 16s and metagenomics sequencing with respect to tumour type and toxicity.

研究者

发起方
香港中文大學

研究点 (1)

Loading locations...

相似试验